Processing heterogeneous biomass: overcoming the hurdles in model building.

Area of Science:

• Biotechnology
• Molecular Biology
• Plant Sciences

Background:

• Plants offer a viable platform for biopharmaceutical protein production, with recent FDA approval of a plant-derived enzyme.
• Transient expression using Agrobacterium tumefaciens is effective for rapid vaccine development during pandemics.

Discussion:

• Transient expression in whole plants exhibits significant variability in recombinant protein levels across leaves.
• This variation complicates process design, increases costs, and can lead to inaccurate conclusions in promoter studies.
• Environmental factors (temperature, plant traits, harvesting) contribute to expression variability.

Key Insights:

• Understanding variability is crucial for both fundamental research and industrial process development in plant-based protein production.
• Transient expression variability can yield misleading data for evaluating expression constructs and regulatory elements.
• Transgenic plants and transient expression in intact plants present distinct challenges for accurate modeling.

Outlook:

• Employing a Design of Experiments (DoE) approach can help mitigate variability and improve the reliability of plant-based protein expression studies.
• Further research into controlling expression variability is essential for advancing plant molecular farming.
• Standardized protocols and advanced modeling are needed to overcome the limitations of transient expression systems.